Introduction
It is a well-established fact that the metabolism of num erous drugs is subject to pronounced inter individual variation, part of which is genetically determined. It would be desirable, therefore, in testing drug metabolism to have a panel of volun teers which is statistically significant for the pa tients eventually to be treated. So far, data on hu man metabolism have been derived almost exclu sively from analogues incorporating radioactive labels. The num ber o f volunteers, however, who may be included in a screening with such com pounds is for ethical reasons limited to the abso lute minimum [1] . Radioisotope studies also af ford, primarily, an overall balance of matter. Structural assignments by necessity require chro m atographic work-up, and correlation of the re tention times of peaks, which have been indicated as radioactive, with those of authentic material. Even so, the procedure provides no absolute proof of a metabolite structure since chrom atographic coincidence can rarely be excluded with certainty. Reliable quantification is further hindered when certain metabolites are constituents also of the regular diet, or of endogenous origin [2] , Many of these problems can be overcome if the drugs to be investigated are labelled with the n atu rally occurring, non-radioactive isotopes l3C and 2H in lieu of the commonly used radioisotopes 14C and 3H. The N M R spectrometer can then be em ployed as detector for these magnetically active nuclei [3] . From individual chemical shifts, 13C or 2H spectra might provide direct structural proof of the respective metabolites. Interference from food constituents or endogenous material thus is ex cluded since the 13C or 2H label can be incorporat ed chemically with 2= 99% enrichment.
Methods

Materials
, several o f the unlabelled and all of the 13C labelled com pounds (series a and b, respectively, Scheme 1) were prepared as de scribed recently [4] , S'-Carboxymethyl-L-cysteine (la ), S-methyl-L-cysteine (5a), and thiodiglycolic acid (9 a) were used as received (Fluka, Neu-Ulm, F.R.G.).
Instrumentation
Proton-decoupled 13C N M R spectra were re corded on Bruker CXP or AM X 300 spectrome- Additional quantitative measurements were car ried out in a similar way in a standard 10 mm l3C probe head with a Bruker WP 80 (20.1 MHz; 35 °C; 10 mm sample tubes). A bout 100,000 FIDs were accum ulated w ithout relaxation delay during 24 h (45° pulses; repetition time 0.7 s; spectral width 5000 Hz).
Sample preparation
Aliquots of the untreated urine samples (1 vol.-% corresponding to 3 -1 0 ml) from the re spective collection periods were adjusted to pH 7.0 by adding a few drops o f 0.1 n N aO H , diluted with 1 m phosphate buffer (pH = 7.0, 1 -4 ml) and D^O (0 .2 -1.5 ml) as internal lock substance, and finally spiked with acetonitrile (104 (il, 2.0 mmol; inter nal standard, 6(CH3) 3.70 ppm relative to sodi um 2,2,3,3-[2H4]-3-(trimethylsilyl)propionate). For long-term measurements (> 5 h), 1 mg/ml of so dium azide was added to prevent bacterial growth. Under these conditions the salt neither reduced sulphoxides nor influenced the spectral pattern.
Studies w ith humans
375 mg (2.08 mmol) or 750 mg (4.17 mmol)] or 5'-[13C]-methyl-L-cysteine [5b, 136 mg (1.00 mmol)] were administered orally to healthy volunteers (lb : n -15; 5b: n = 1). Urine was collected in fractions over 24 h according to the usual protocol [5] , and kept frozen (-2 0 °C) until ex vivo N M R analysis.
Results and Discussion
In order to test the feasibility of the N M R ap proach, we have first measured the 13C N M R spec trum o f untreated hum an urine. Significant signals in this "native" spectrum ( Fig. 1 a) , apart from those o f the added standard C H 3CN, arise from urea, creatinine, and hippuric acid only. In com parison, Fig. l b shows the 13C spectrum of a hu man urine sample, likewise untreated and collected from 0 -8 h after adm inistration of the muco lytic agent .S-carboxymethyl-L-cysteine (lb , see Scheme 1), labelled in one methylene group with 5s 99% l3C. The two prom inent signals in the spec trum are due to unchanged 1 b and thiodiglycolic acid (9 b, see Scheme 1) which in this study was identified for the first time as the main metabolite of 1. These peaks, pertaining to the applied drug, by far surpass, in their intensity, all signals of en dogenous material (cf. Fig. 1 a) . E x vivo m etabol ites of a 13C labelled drug thus appear clearly set off from the background o f the m ultitude of endo genous com pounds (biological noise) in the renal excretions. The samples from all fifteen volunteers displayed similar spectral patterns. After 8 h, for instance, most of the parent drug has been elimi nated whereas residual am ounts of 9 b and 10 b are still excreted after 24 h (data not shown).
Additional smaller signals are due to further me tabolites formed and/or excreted on the <10% level. Among these, the sulphoxide 10b has been identified for the first time with the N M R method; it is present in the 0 -8 h sample with 1 -6 % of the applied dose. In contrast, no trace can be detected of the metabolites (in this case 13C-labelled) postu lated in a previous study [6] 
, e.g. ^-methyl-L-cysteine (5 b), jV-acetyl-S-methyl-L-cysteine (7 b), or
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Scheme l. the respective sulphoxides 6 b and 8 b. Even S'-carboxymethyl-L-cysteine-.S-oxide (2b), the pro posed main metabolite, is detected only in minute am ounts (=£2% o f the dose in the 0 -8 h period). The absence of significant am ounts of these com pounds is established, beyond any doubt, by add ing 50 nmol each o f authentic 13C-labelled material (Fig. 1 c) . The spectral trace in Fig. 1 The N M R m ethod thus allows, after adminis tration o f a 13C-labelled drug, simultaneous detec tion, with concom itant structural characterization, of all renally excreted biotransform ation products which retain the label and are excreted with at least 0 .1 -1 % (depending, o f course, on applied dose and volume intake before and during the sampling period). The biological samples can be measured directly, without any discriminative m anipula tions, which is especially advantageous in the case of chemically sensitive and/or volatile structures. M etabolites with the 13C label in a methyl or m eth ylene group furtherm ore allow for quantitative evaluation; this is an unexpected bonus and has been checked very carefully with authentic labelled material [7] , Thus, the mean 24 h urinary excretion was balanced as follows (% of the dose): parent drug 1 (~20% ), m ajor metabolite 9 (=20% ), m inor metabolites 10 (=13% ) and 2 (= 1 % , sum of diastereoisomers). This balance, as well as an indi vidual total recovery o f up to 70%, has been veri fied by methodologically independent measure ments with newly developed HPLC [8] and G C/M S [9] techniques.
Chemical reactions, e.g. for obtaining addition al confirm ation o f individual m etabolite struc tures, can be performed directly on the native sam ple in the N M R tube. Thus, all thioethers are transform ed quantitatively into the respective sulphoxides if an approxim ately stoichiometric am ount of H 20 2 is added to the samples shown in Fig. 1 b and 1 c. U nder the prevailing mild reaction conditions, the sulphoxides formed are not in turn oxidized further to the corresponding sulphones [4] , If these samples or untreated urines are lyo philized, and the measurements repeated in D^O, one observes selective "loss" o f those carbon reso nances that originate from methylene or methyl groups, adjacent to the sulphoxide groups (not shown), due to slow H/D exchange [4] , In a complementary experiment, S-methyl-L-cysteine (5 b), with the l3C label in the methyl group, was applied orally (136 mg, 1.00 mmol). The renal excretions, collected for three successive 4 h periods, showed no trace o f either unchanged drug 5 b or its 7V-acetyl derivative 7 b, but rather the signals of a mixture of the diastereoisomeric S-methyl-L-cysteine-S-oxides 6b [( + )- (5) [10] . There is no trace, however, o f the respective signals in the 13C spectra. On the basis of the stable isotope methodology reported here, a genetically determined polym orphism of S-carboxymethyl-L-cysteine sulphoxidation in respect to the formation of cysteinyl sulphoxides [5] can not be verified.
Recent results indicate that the N M R approach is not restricted to carbon. W hen synthetic, and selectively deuteriated analogues of the alkaloid /-sparteine [11] are administered to rats and hu mans, the parent drug, and its metabolites excreted in the urine, can be m onitored directly by :H N M R [12] . The pronounced differences in regioand stereoselectivity, observed for the biotransfor mation, clearly dem onstrate ex vivo N M R spec troscopy of stable isotope-labelled drugs as a pow erful tool for rapidly uncovering metabolite p at terns and species differences in drug metabolism.
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